N02C1: A phase III randomized, placebo-controlled, double-blind trial of risedronate for prevention of bone loss in premenopausal women undergoing adjuvant chemotherapy for breast cancer (BC)
Year: 2008
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: S. L. Hines, B. A. Mincey, J. A. Sloan, S. P. Thomas, E. G. Chottiner, C. L. Loprinzi, P. J. Atherton, M. D. Carlson, M. Salim, E. A. Perez
Language: English
Subfield: Orthopedics and Sports Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2246450047